| Similar Articles |
|---|
 |
The Motley Fool
September 28, 2006
Ralph Casale |
A Second Sell-Off at Molecular Devices The company, which makes equipment used in drug development, is struggling with lumpy revenues.   |
The Motley Fool
January 4, 2007
Ralph Casale |
Picks and Shovels of Biotechnology Biotech investors will continue to venture into the dark mines of burgeoning pharmaceutical firms. There is certainly gold to be found in some of them, just remember to invest in some of the hardware stores of biotechnology along the way. |
The Motley Fool
May 5, 2004
Brian Gorman |
Albany Molecular Gets Out-Outsourced Albany Molecular Research, provider of chemistry services to biotech and pharmaceutical clients, is suffering from the loss of business to low-cost competitors overseas. |
The Motley Fool
March 21, 2005
Stephen D. Simpson |
Farewell, CTI Molecular The rebounding medical imaging company gets snapped up by Siemens. Some investors may be thinking that management is selling too soon and for too little. |
The Motley Fool
September 22, 2005
Jack Uldrich |
TINY Magnifies Its Hunt The nanotech venture capital firm announces its participation in two big nano private financings. Investors, take note. |
The Motley Fool
October 25, 2005
Brian Gorman |
Albany Molecular's Mixed Bag The pharma's contract services side is improving, and Allegra royalties won't disappear. Even so, the company seems to be facing some tough times ahead. Investors, take note. |
Job Journal
September 21, 2003
Marty Nemko |
Biotech = Opportunity What this strong growth industry could offer you |
Bio-IT World
November 2006
Alan S. Louie |
Signs of Life in Life Sciences IT Spending Pharmaceutical and other life science companies are confronting explosive growth in the volume of data being generated from R&D programs including high-throughput discovery instrumentation, molecular imaging (pre-clinical and clinical), and access to external data sources. |
Chemistry World
July 15, 2014
Philip Ball |
Molecular clocks may probe fundamental laws A new proposal for using molecules rather than atoms for ultra-precise measurement of frequencies could help to probe whether there are fundamental laws of physics beyond the ones we know already. |
The Motley Fool
August 14, 2007
Brian Orelli |
Drugmaker Growth Without the FDA Do you have one of those stomachs that just can't take the ups and downs of clinical trial data and FDA approval decisions? Buy stocks in the companies that support the drug makers. |
Information Today
July 14, 2015 |
Nature Publishing Group Will Add Phenomics Journal to Its Portfolio Nature Publishing Group and Fudan University in Shanghai agreed to co-publish a new interdisciplinary, open access journal, npj Molecular Phenomics. |
CIO
June 1, 2003
Bob Violino |
Powerful DNA Portable computer vendors like to boast about their small and lightweight devices. But their best efforts are nothing compared with programmable molecular computing machines composed of an enzyme and DNA molecules. |
The Motley Fool
February 13, 2006
Brian Gorman |
Albany Molecular's Royalty Squeeze Declining royalty revenue is likely to keep buffeting the contract services provider. Investors, take note. |
The Motley Fool
May 11, 2006
Brian Gorman |
Albany Molecular Stabilizes The chemistry services company's results are still slumping, but the worst appears to be over. Investors, take note. |
